Fusion Antibodies Plc (FAB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2015 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 104 |
| Other current assets | 231 |
| TOTAL | $335 |
| Non-Current Assets | |
| PPE Net | 36 |
| TOTAL | $36 |
| Total Assets | $371 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 144 |
| TOTAL | $182 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 20 |
| TOTAL | $20 |
| Total Liabilities | $202 |
| Shareholders' Equity | |
| Common Shares | 548 |
| Retained earnings | -6,540 |
| TOTAL | $169 |
| Total Liabilities And Equity | $371 |